Abstract
The potential deleterious effects of extractables/leachables in pharmaceutical products and the need to preserve product safety throughout its shelf life have led the three major pharmacopoeias (USP, EP, JP) to require extractable and toxicity testing of container/closure systems. To that, a HPLC/UV method was developed and validated for the detection of zinc dibutyl dithiocarbamate (ZDBC) as potential extractable from pharmaceutical container closure system of eye drops solutions. The method consists of direct extraction of the analyte with chloroform; the lower layer was evaporated to dryness and further reconstituted with acetonitrile. The chromatographic separation was performed on a Nova-Pak C18 column using as mobile phase a mixture of acetonitrile:water. Calibration curves were linear and relative standard deviation was sufficient. Detection limit of ZDBC was found to be 0.015 μg/mL. The HPLC method was further applied in seven currently marketed eye drops solutions, confirming its applicability for monitoring dithiocarbamates migration from container closure systems into the eye drops solutions.
Similar content being viewed by others
References
Jenke, D., Garber, M.J., and Zietlow, D., J. Liq. Chromatogr. Rel. Technol., 2005, vol. 28, p. 199.
Guideline on Impurities in New Drug Substances, Q3AR, Geneva: ICH, 2002.
Guidance for Industry on Impurities in New Drug Products, Q3BR, Rockville: FDA, 2003.
Hamilton, G., Radiology, 1984, vol. 152, p. 387.
Lieberman, H.A. and Kanig, J.L., The theory and Practice of Industrial Pharmacy, Philadelphia: Lea and Febiger, 1976, p.693.
Lachman, L., Urbnyi, T., and Weinstein, S., J. Pharm. Sci., 1963, vol. 52, p. 244.
Bennett, C.L., Luminari, S., Nissenson, A.R., Tallman, M.S., Klinge, S.A., McWilliams, N., Mckoy, J.M., Kim, B., Lyons, E.A., Trifilio, S.M., Raisch, D.W., Evens, A.M., Kuzel, T.M., Schumock, G.T., Belknap, S.M., Locatelli, F., Rossert, J., and Casadevall, N., New Engl. J. Med., 2004, vol. 351, p. 1403.
The United States Pharmacopeia 31-National Formulary 26, United States Pharmacopoeia Convention, 2008, section 〈381〉, 2004, p. 144.
The United States Pharmacopeia 31-National Formulary 26, United States Pharmacopoeia Convention, 2008, section 〈661〉, 2008, p. 251.
Guidance for Industry on Container Closure Systems for Packaging Human Drugs and Biologics, Rockville: FDA, 1999.
Draft Guidance for Industry on Metered Dose Inhaler and Dry Powder Inhaler Drug Products, Rockville: FDA, 1998.
Spray and Inhalation Guidance for Industry on Nasal Solution, Suspension, and Spray Drug. Products-Chemistry, Manufacturing, and Controls Documentation, Rockville: FDA, 2002.
Norwood, D.L., Granger, A.T., and Paskiet, D.M., Encyclopedia of Pharmaceutical Technology, New York: Marcel Dekker Encyclopedias, 2006, p. 1693.
Norwood, D.L., Paskiet, D., Ruberto, M., Feinberg, T., Schroeder, A., Poochikian, G., Wang, Q., Deng, T.J., DeGrazio, F., Munos, M.K., and Nagao, L.M., Pharm. Res. 2008, vol. 25(4), p. 727.
Electronic resource, http://www.pqri.org/pdfs/LE-Recommendations_to_FDA_09-29-06.pdf (accessed 24 July 2012).
Food and Drug Administration, 21 Code of Federal Regulations, 4-1-11 ed., 2011, Subpart E, section 211.94, p. 150.
The European Pharmacopoeia, 4th ed., 2002, section 3.2.9, p. 316.
The Japanese Pharmacopoeia, 14th ed., 2001, section 59, p. 92.
Norwood, D.L., Jenke, D., Manolescu, C., Pennino, S., and Grinberg, N., J. Liq. Chromatogr. Rel. Technol., 2009, vol. 32, p. 1768.
Hansson, C., Management of Positive Patch Test Reactions, Berlin: Springer, 2003, p. 13.
Hedenstedt, A., Rannug, V., Ramel, C., and Wachtmeister, C.A., Mutation Research, 1979, vol. 68, p. 313.
Rannug, A., Rannug, V., and Ramel, C., Progr. Clin. Biol. Res., 1984, vol. 141, p. 407.
Ball, D., Blanchard, J., Jacobson-Kram, D., McClellan, R., McGovern, T., Norwood, D.L., Vogel, M., Wolff, R., and Nagao, L., Tox. Sci., 2007, vol. 97(2), p. 226.
Rabek, J.F., Photostabilization of Polymers: Principles and Applications, London: Elsevier Applied Science, 1990.
Xiao, B., Gozob, S.K. and Herz, L., J. Pharm. Biomed. Anal., 2007, vol. 43, p. 558.
Depree, G.J., Bledsoe, T.A., and Siegel, P.D., J. Chromatogr. Sci., 2004, vol. 42, p. 80.
Depree, G.J., Bledsoe, T.A., and Siegel, P.D., Contact Dermatitis, 2005, vol. 53, p. 107.
Ellin, R.I., Kaminskis, A., Zvirblis, P., Sultan, W.E., and Shutz, M.B., J. Pharm. Sci., 1985, vol. 74, p. 788.
Milano, C.J. and Bailey, L.C., J. Pharm. Sci. Technol., 1999, vol. 53, p. 202.
Zhang, F., Chang, A., Karaisz, K., Feng, R., and Cai, J., J. Pharm. Biomed. Anal., 2004, vol. 34, p. 841.
Guidance on the performance of analytical methods and the interpretation of results, European Commission, 2002/657/EC, 2002.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Vardakou, I., Karampela, S., Papoutsis, I. et al. Migration study of zinc dibutyldithiocarbamate in eye drops solutions. J Anal Chem 69, 1096–1101 (2014). https://doi.org/10.1134/S1061934814110136
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934814110136